Skandinaviska Enskilda Banken AB publ Has $10.04 Million Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Skandinaviska Enskilda Banken AB publ grew its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.1% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 16,615 shares of the biotechnology company’s stock after buying an additional 958 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Axon Enterprise were worth $10,040,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Groupama Asset Managment acquired a new stake in Axon Enterprise in the third quarter valued at $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise in the third quarter valued at about $120,553,000. Proficio Capital Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at about $78,414,000. Westfield Capital Management Co. LP raised its position in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the period. Finally, Assenagon Asset Management S.A. raised its position in shares of Axon Enterprise by 328.7% in the fourth quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company’s stock valued at $86,354,000 after purchasing an additional 111,405 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research report on Monday. Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group increased their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research report on Monday, January 27th. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Finally, Robert W. Baird lifted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $604.67.

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $556.26 on Friday. The firm has a 50 day moving average of $594.32 and a 200-day moving average of $532.91. The stock has a market capitalization of $42.62 billion, a PE ratio of 143.74, a PEG ratio of 5.17 and a beta of 1.12. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Insider Activity

In related news, Director Michael Garnreiter sold 1,000 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the sale, the director now directly owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. The trade was a 3.96 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,146 shares of company stock worth $3,262,847. 6.10% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.